Literature DB >> 33871202

Topical imiquimod as a neo-adjuvant chemotherapy for cartilage salvage in the treatment of nodular basal cell carcinomas of the head and neck.

Saurabh Singh1, M Bandhala Rajan1, Abhishek Bhardwaj1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33871202     DOI: 10.25259/IJDVL_414_20

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  5 in total

1.  Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.

Authors:  James M Spencer
Journal:  Dermatol Surg       Date:  2006-01       Impact factor: 3.398

2.  Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.

Authors:  S van der Geer; J Martens; J van Roij; E Brand; J U Ostertag; M E J M Verhaegh; H A M Neumann; G A M Krekels
Journal:  Br J Dermatol       Date:  2012-05-21       Impact factor: 9.302

Review 3.  Topical pharmacotherapy for skin cancer: part II. Clinical applications.

Authors:  Giuseppe Micali; Francesco Lacarrubba; Maria Rita Nasca; Salvatore Ferraro; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2014-06       Impact factor: 11.527

4.  Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.

Authors:  David F Butler; Palak K Parekh; Armando Lenis
Journal:  Dermatol Surg       Date:  2008-11-19       Impact factor: 3.398

5.  Guidelines of care for the management of basal cell carcinoma.

Authors:  John Y S Kim; Jeffrey H Kozlow; Bharat Mittal; Jeffrey Moyer; Thomas Olencki; Phillip Rodgers
Journal:  J Am Acad Dermatol       Date:  2018-01-10       Impact factor: 11.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.